GGrantIndex
Sort

65,743 grants matching single cell sequencing

LncRNA H19 in Cholestatic Liver Diseases

$629,582
Huiping Rose Zhou · Virginia Commonwealth University · R56 · FY2023 · DK

Mechanisms by which human milk-derived oligosaccharides protect intestinal barrier and attenuate inflammation

$629,556
Fang Yan · Vanderbilt University Medical Center · R01 · FY2024 · DK

Developmental genes, miRNAs and adipose tissue

$629,531
C Ronald Kahn · Joslin Diabetes Center · R01 · FY2020 · DK

Developmental genes, miRNAs and adipose tissue

$629,531
C Ronald Kahn · Joslin Diabetes Center · R01 · FY2021 · DK

Targeting Nuclear HSF1 as a Novel Anti-HCMV Strategy

$629,516
Gary Ching Tao Chan · Upstate Medical University · R01 · FY2025 · AI

Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells

$629,515
Ettore Appella · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Modeling mtDNA Disease in vivo

$629,508
Stephen Carl Ekker · University Of Texas At Austin · R24 · FY2024 · OD

Modeling mtDNA Disease in vivo

$629,508
Stephen Carl Ekker · University Of Texas At Austin · R24 · FY2025 · OD

Deciphering the Molecular Mechanism of Pediatric Interstitial Lung Disease to Advance Targeted Therapies

$629,498
Jeremy Binder Katzen · University Of Pennsylvania · R01 · FY2025 · HL

miR-615, AKT/eNOS signaling, and angiogenesis

$629,463
Mark W Feinberg · Brigham And Women'S Hospital · R01 · FY2023 · HL

APOE Allele Switching as a Therapeutic Approach for Alzheimer's Disease

$629,419
Lance Allen Johnson · University Of Kentucky · R01 · FY2025 · AG

Identification and functional impact of NAFLD associated genetic variants

$629,403
Elizabeth K Speliotes · University Of Michigan At Ann Arbor · R01 · FY2018 · DK

HBB gene-editing for treating sickle cell disease

$629,375
Gang Bao · Rice University · R01 · FY2020 · HL

Employing viruses to unravel the functional significance of the m5C epitranscriptome

$629,355
Charles M. Rice · Rockefeller University · R01 · FY2025 · AI

Molecular origins and impact of APOBEC3 mutagenesis in cancer

$629,354
John Maciejowski · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA

Inhibiting Neovascularization and Subretinal Fibrosis in Neovascular Age-Related Macular Degeneration

$629,351
Weiquan (wendy) Zhu · University Of Utah · R01 · FY2023 · EY

Mechanisms of DNA-Specific Autoimmunity in Systemic Lupus Erythematosus

$629,341
Boris Reizis · New York University School Of Medicine · R01 · FY2025 · AR

Focal Adhesion Kinase inhibition for dual targeting of osteosarcoma cells and the tumor microenvironment to prevent metastasis

$629,341
Daniel Patrick Regan · Colorado State University · R37 · FY2025 · CA

Control of cardiomyocyte cell cycle by REST in heart failure and regeneration

$629,301
Bin Zhou · Albert Einstein College Of Medicine · R01 · FY2022 · HL

Integrative single cell analyses of inflammation-derived circulating hybrid cells to identify aggressive disease

$629,276
Melissa H Wong · Oregon Health & Science University · R01 · FY2021 · CA

Glycosaminoglycan Targeting Treatment for Prostatic Hyperplasia and Fibrosis

$629,250
Vinata B Lokeshwar · Augusta University · R01 · FY2024 · DK

Germline and Somatic Genomic Studies in CLL Minorities

$629,224
Susan L Slager · Mayo Clinic Rochester · R01 · FY2024 · CA

Dynamics of the cellular and molecular architecture of human pulmonary TB granulomas

$629,213
Robert L Modlin · University Of California Los Angeles · R01 · FY2025 · AI

Functional development of interneurons that mediate the vestibulo-ocular reflex

$629,200
David Schoppik · New York University School Of Medicine · R01 · FY2020 · DC

Single-cell direct RNA sequencing using electrical zero-mode waveguides and engineered reverse transcriptases

$629,198
Meni Wanunu · Northeastern University · R01 · FY2021 · HG